Search

Author/Creator Hennermann, J. B.

1. Impact of immunosuppressive therapy on therapy‐neutralizing antibodies in transplanted patients with Fabry disease. (26th July 2017)

Authors:
Lenders, M.; Oder, D.; Nowak, A.; Canaan‐Kühl, S.; Arash‐Kaps, L.; Drechsler, C.; Schmitz, B.; Nordbeck, P.; Hennermann, J. B.; Kampmann, C.; Reuter, S.; Brand, S.‐M.; Wanner, C.; Brand, E.
Journal:
Journal of internal medicine
Issue:
Volume 282:Number 3(2017)
Page Start:
241
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. PB2314: OLIPUDASE ALFA FOR ADULTS WITH ACID SPHINGOMYELINASE DEFICIENCY: IMPROVEMENTS IN CROSSOVER PLACEBO PATIENTS AND FURTHER IMPROVEMENTS IN ORIGINAL OLIPUDASE ALFA PATIENTS AFTER 2 YEARS IN ASCEND TRIAL. (23rd June 2022)

Authors:
Villarrubia, J.; Wasserstein, M.; Barbato, A.; Gallagher, R. C.; Giugliani, R.; Guelbert, N. B.; Hennermann, J. B.; Hollak, C.; Ikezoe, T.; Lachmann, R.; Lidove, O.; Mabe, P.; Mengel, E.; Scarpa, M.; Senates, E.; Tchan, M.; Thurberg, B. L.; Yarramaneni, A.; Rawlings, A. M.; Kim, Y.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
2183
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search